FDA MedWatch Safety AlertsUnited States21 September 2026
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
This is an official announcement record
Firsthand records what FDA MedWatch Safety Alerts announced and links to the original. The wording below is theirs, not ours.
ROCHESTER, MI– September 18, 2026 –Par Health is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) to the hospital level. The product is being recalled due to the presence of particulate matter identified as cellulose or stopper materia
Read the official announcement
Opens www.fda.gov
More from FDA MedWatch Safety Alerts
- Greenwich Rx Issues Voluntary Nationwide Recall of Compounded Glutathione Due to Elevated Endotoxin Levels1 October 2026
- Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Catheters25 September 2026
- Heart Pump Controller Recall: Abiomed Removes Automated Impella Controllers24 September 2026
- Convenience Kit Correction: Becton Dickinson Issues Correction for Kits and Procedure Trays Containing Recalled Sodium Chloride Ampules24 September 2026
- Early Alert: Ventilator Issue from React Health23 September 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.